Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth of 17%. Consolidated Net Profit of ₹287 Crore, up 343% from -(₹118) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.48, up 343% from -(₹3.49) in the same quarter of the previous year.
